Jonathan D. Glass

Active 1991–2026

141
Papers
23,994
Citations
83
h-index
135
i10-index

Citations

Citations per year for Jonathan D. Glass1977: 1 citations1992: 4 citations1993: 19 citations1994: 47 citations1995: 50 citations1996: 51 citations1997: 79 citations1998: 120 citations1999: 151 citations2000: 72 citations2001: 85 citations2002: 88 citations2003: 94 citations2004: 82 citations2005: 115 citations2006: 94 citations2007: 72 citations2008: 81 citations2009: 104 citations2010: 114 citations2011: 152 citations2012: 222 citations2013: 249 citations2014: 245 citations2015: 229 citations2016: 280 citations2017: 285 citations2018: 281 citations2019: 785 citations2020: 913 citations2021: 885 citations2022: 851 citations2023: 811 citations2024: 1,138 citations2025: 609 citations2026: 22 citations1978–1991: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,628 citing papers, 31% of this breakdownUnited Kingdom: 1,102 citing papers, 9.4% of this breakdownGermany: 664 citing papers, 5.7% of this breakdownItaly: 629 citing papers, 5.4% of this breakdownChina: 595 citing papers, 5.1% of this breakdownCanada: 479 citing papers, 4.1% of this breakdownAustralia: 423 citing papers, 3.6% of this breakdownFrance: 417 citing papers, 3.5% of this breakdownNetherlands: 400 citing papers, 3.4% of this breakdownSpain: 307 citing papers, 2.6% of this breakdownSweden: 295 citing papers, 2.5% of this breakdownJapan: 287 citing papers, 2.4% of this breakdown
0%31%Other 21.3%

Fields

  • Medicine56.1%
  • Biochemistry, Genetics and Molecular Biology19.6%
  • Neuroscience12.8%
  • Immunology and Microbiology7.9%
  • Engineering0.8%
  • Computer Science0.7%
  • Other2.1%

Topics

  • Amyotrophic Lateral Sclerosis Research12.1%
  • Alzheimer's disease research and treatments7.2%
  • Neurogenetic and Muscular Disorders Research7%
  • Neuroinflammation and Neurodegeneration Mechanisms4.9%
  • Parkinson's Disease Mechanisms and Treatments2.7%
  • HIV Research and Treatment2.6%
  • Other63.5%

Coauthors

All papers

Open in search
  1. Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2022 cited by 850

  2. Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Patricia L. Andres, Suma Babu, Marianne Chase, Derek D’Agostino, Samuel P. Dickson, Noel Ellison, Meghan Hall, Kent Hendrix, Gale Kittle, Michelle McGovern, Joseph Ostrow, Lindsay Pothier, Rebecca Randall, Jeremy M. Shefner, Alexander Sherman, Eric Tustison, Prasha Vigneswaran, Jason Walker, Hong Yu, James Chan, Janet Wittes, Joshua Cohen, Justin Klee, Kent Leslie, Rudolph E. Tanzi, Walter Gilbert, Patrick Yeramian, David Schoenfeld, Merit Cudkowicz - New England Journal of Medicine 2020 cited by 524

  3. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert C. Green, Ekaterina Rogaeva, Peter St George‐Hyslop, Steven E. Arnold, Robert C. Barber, Thomas G. Beach, Eileen H. Bigio, James D. Bowen, Adam Boxer, James R. Burke, Nigel J. Cairns, Chris Carlson, Regina M. Carney, Steven L. Carroll, Helena C. Chui, David G. Clark, Jason J. Corneveaux, Carl W. Cotman, Jeffrey L. Cummings, Charles DeCarli, Steven T. DeKosky, Ramon Diaz‐Arrastia, Malcolm Dick, Dennis W. Dickson, William G. Ellis, Kelley M. Faber, Kenneth B. Fallon, Martin R. Farlow, Steven H. Ferris, Matthew P. Frosch, Douglas Galasko, Mary Ganguli, Marla Gearing, Daniel H. Geschwind, Bernardino Ghetti, John R. Gilbert, Sid Gilman, Bruno Giordani, Jonathan D. Glass, John H. Growdon, Ronald L. Hamilton, Lindy E. Harrell, Elizabeth Head, Lawrence S. Honig, Christine M. Hulette, Bradley T. Hyman, Gregory A. Jicha, Lee‐Way Jin, Nancy Johnson, Jason Karlawish, Anna Karydas, Jeffrey Kaye, Ronald Kim, Edward H. Koo, Neil W. Kowall, James J. Lah, Allan I. Levey, Andrew P. Lieberman, Oscar L. López, Wendy J. Mack, Daniel Marson, Frank Martiniuk, Deborah C. Mash, Eliezer Masliah, Wayne C. McCormick, Susan M. McCurry, Andrew McDavid, Ann C. McKee, Marsel Mesulam, Bruce L. Miller and 55 more - Nature Genetics 2011 cited by 2,014

  4. Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Toby A. Ferguson - New England Journal of Medicine 2020 cited by 543

  5. TDP-43 pathology disrupts nuclear pore complexes and nucleocytoplasmic transport in ALS/FTD

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature Neuroscience 2018 cited by 604

  6. Integrated proteomics reveals brain-based cerebrospinal fluid biomarkers in asymptomatic and symptomatic Alzheimer’s disease

    Authors: , , , , , , , , , , , , , - Science Advances 2020 cited by 393

  7. Mis-spliced transcripts generate de novo proteins in TDP-43–related ALS/FTD

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anantharaman Shantaraman, Lingyan Ping, Yuka Koike, Björn Oskarsson, Nathan P. Staff, Duc M. Duong, Aisha Ahmed, Maria Secrier, Jernej Ule, Steven Jacobson, Daniel S. Reich, Jonathan D. Rohrer, Andrea Malaspina, Dennis W. Dickson, Jonathan D. Glass, Alessandro Ori‬‬, Nicholas T. Seyfried, Manolis Maragkakis, Leonard Petrucelli, Pietro Fratta, Michael E. Ward - Science Translational Medicine 2024 cited by 158

  8. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jack W. Miller, Soragia Athina Gkazi, Ammar Al‐Chalabi, Leonard H. van den Berg, Jan H. Veldink, Vincenzo Silani, Nicola Ticozzi, Christopher E. Shaw, Robert H. Baloh, Stanley H. Appel, Ericka Simpson, Clotilde Lagier‐Tourenne, Stefan M. Pulst, Summer Gibson, John Q. Trojanowski, Lauren Elman, Leo McCluskey, Murray Grossman, Neil A. Shneider, Wendy K. Chung, John Ravits, Jonathan D. Glass, Katherine B. Sims, Vivianna M. Van Deerlin, Tom Maniatis, Sebastian Hayes, Alban Ordureau, Sharan Swarup, John E. Landers, Frank Baas, Andrew S. Allen, Richard Bedlack, J. Wade Harper, Aaron D. Gitler, Guy A. Rouleau, Robert H. Brown, Matthew B. Harms, Gregory M. Cooper, Tim Harris, R Myers, David B. Goldstein - Science 2015 cited by 992

  9. A Multi-network Approach Identifies Protein-Specific Co-expression in Asymptomatic and Symptomatic Alzheimer’s Disease

    Authors: , , , , , , , , , , , , , , , , - Cell Systems 2016 cited by 536

  10. Answer ALS, a large-scale resource for sporadic and familial ALS combining clinical and multi-omics data from induced pluripotent cell lines

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michael J. Workman, Ritchie Ho, Stacia K. Wyman, Jennifer Roggenbuck, Matthew B. Harms, Jennifer Stocksdale, Ricardo Miramontes, Keona Q. Wang, Vidya Venkatraman, Ronald Holewenski, Niveda Sundararaman, Rakhi Pandey, Danica-Mae Manalo, Aneesh Donde, Nhan Huynh, Miriam Adam, Brook T. Wassie, Edward Vertudes, Naufa Amirani, Krishna Raja, Reuben Thomas, Lindsey R. Hayes, Alex Lenail, Aianna Cerezo, Sarah Luppino, Alanna Farrar, Lindsay Pothier, Carolyn Prina, Todd E. Morgan, Arish Jamil, Sarah Heintzman, Jennifer Jockel‐Balsarotti, Elizabeth Karanja, Jesse Markway, Molly McCallum, Ben Joslin, Deniz Alibazoglu, Stephen J. Kolb, Senda Ajroud‐Driss, Robert H. Baloh, Daragh Heitzman, T. W. Miller, Jonathan D. Glass, Natasha Leanna Patel-Murray, Hong Yu, Ervin Sinani, Prasha Vigneswaran, Alexander Sherman, Omar Ahmad, Promit Roy, Jay Beavers, Steven R. Zeiler, John W. Krakauer, Carla Agurto, Guillermo Cecchi, Mary Bellard, Yogindra Raghav, Karen Sachs, Tobias Ehrenberger, Elizabeth Bruce, Merit Cudkowicz, Nicholas J. Maragakis, Raquel Norel, Jennifer E. Van Eyk, Steven Finkbeiner, James D. Berry, Dhruv Sareen, Leslie M. Thompson, Ernest Fraenkel, Clive N. Svendsen and 1 more - Nature Neuroscience 2022 cited by 158

  11. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man

    Authors: , , , , , , , , - Experimental Neurology 2004 cited by 1,343

  12. Long‐term survival of participants in the CENTAUR trial of sodium phenylbutyrate‐taurursodiol in amyotrophic lateral sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Namita Goyal, Gary L. Pattee, Patricia L. Andres, Suma Babu, Marianne Chase, Derek D’Agostino, Meghan Hall, Gale Kittle, Matthew Eydinov, Michelle McGovern, Joseph Ostrow, Lindsay Pothier, Rebecca Randall, Jeremy M. Shefner, Alexander Sherman, Maria E. St. Pierre, Eric Tustison, Prasha Vigneswaran, Jason Walker, Hong Yu, James Chan, Janet Wittes, Zi‐Fan Yu, Joshua Cohen, Justin Klee, Kent Leslie, Rudolph E. Tanzi, Walter Gilbert, Patrick Yeramian, David Schoenfeld, Merit Cudkowicz - Muscle & Nerve 2020 cited by 180

  13. Genome-wide identification of the genetic basis of amyotrophic lateral sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philippe Couratier, Orla Hardiman, Russell McLaughin, Marc Gotkine, Vivian E. Drory, Nicola Ticozzi, Vincenzo Silani, Jan H. Veldink, Leonard H. van den Berg, Mamede de Carvalho, Jesús S. Mora Pardina, Mónica Povedano, Peter M. Andersen, Markus Weber, Nazlı Başak, Ammar Al‐Chalabi, Christopher E. Shaw, Pamela J. Shaw, Karen Morrison, John E. Landers, Jonathan D. Glass, Jan H. Veldink, Laura Ferraiuolo, Pamela J. Shaw, M Snyder - Neuron 2022 cited by 122

  14. NEK1 variants confer susceptibility to amyotrophic lateral sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Frank Baas, Anneke J. van der Kooi, Marianne de Visser, Anneloor L.M.A. ten Asbroek, Peter C. Sapp, Diane McKenna‐Yasek, Meraida Polak, Seneshaw Asress, José Luís Muñoz-Blanco, Tim M. Strom, Thomas Meitinger, Karen Morrison, Giuseppe Lauria, Kelly L. Williams, P. Nigel Leigh, Garth A. Nicholson, Ian P. Blair, Claire S. Leblond, Patrick A. Dion, Guy A. Rouleau, Hardev Pall, Pamela J. Shaw, Martin R. Turner, Kevin Talbot, Franco Taroni, Khrista Boylan, Marka van Blitterswijk, Rosa Rademakers, Jesús Esteban‐Pérez, Alberto García‐Redondo, Phillip Van Damme, Wim Robberecht, Adriano Chiò, Cinzia Gellera, Carsten Drepper, Michael Sendtner, Antonia Ratti, Jonathan D. Glass, Jesús S. Mora, Nazlı Başak, Orla Hardiman, Albert C. Ludolph, Peter M. Andersen, Jochen H. Weishaupt, Robert H. Brown, Ammar Al‐Chalabi, Vincenzo Silani, Christopher E. Shaw, Leonard H. van den Berg, Jan H. Veldink, John E. Landers - Nature Genetics 2016 cited by 294

  15. Safety, tolerability, and pharmacokinetics of antisense oligonucleotide BIIB078 in adults with C9orf72-associated amyotrophic lateral sclerosis: a phase 1, randomised, double blinded, placebo-controlled, multiple ascending dose study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Neurology 2024 cited by 70

  16. Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alberto García‐Redondo, Jesús Esteban‐Pérez, Cinzia Tiloca, Federico Verde, Stefano Duga, Nigel Leigh, Hardev Pall, Karen Morrison, Ammar Al‐Chalabi, Pamela J. Shaw, Janine Kirby, Martin R. Turner, Kevin Talbot, Orla Hardiman, Jonathan D. Glass, Jacqueline de Belleroche, Masatoshi Maki, Stephen E. Moss, Christopher C.J. Miller, Cinzia Gellera, Antonia Ratti, Safa Al‐Sarraj, Robert H. Brown, Vincenzo Silani, John E. Landers, Christopher E. Shaw - Science Translational Medicine 2017 cited by 247

  17. Project MinE: study design and pilot analyses of a large-scale whole-genome sequencing study in amyotrophic lateral sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ian P. Blair, Jonathan D. Glass, Orla Hardiman, Winston Hide, Pamela J. Shaw, Jesus S. Mora, Karen E. Morrison, Naomi R. Wray - European Journal of Human Genetics 2018 cited by 198

  18. Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shaun Purcell, Sven Cichon, Markus M. Nöthen, H‐Erich Wichmann, Stefan Schreiber, Sita H. Vermeulen, Lambertus A. Kiemeney, John H. J. Wokke, Simon Cronin, Russell L. McLaughlin, Orla Hardiman, Katsumi Fumoto, R. Jeroen Pasterkamp, Vincent Meininger, Judith Melki, P. Nigel Leigh, Christopher E. Shaw, John E. Landers, Ammar Al‐Chalabi, Robert H. Brown, Wim Robberecht, Peter M. Andersen, Roel A. Ophoff, Leonard H. van den Berg - Nature Genetics 2009 cited by 404

  19. Genetic variability in sporadic amyotrophic lateral sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Leonard H. van den Berg, Ammar Al‐Chalabi, Jan H. Veldink, Philip Van Damme - Brain 2023 cited by 86

  20. Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Antonia Ratti, Cinzia Gellera, Daryl A. Bosco, Gary J. Bassell, Vincenzo Silani, Vivian E. Drory, Robert H. Brown, John E. Landers - Nature 2012 cited by 603

  21. A proteomic network approach across the ALS‐FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain

    Authors: , , , , , , , , - EMBO Molecular Medicine 2017 cited by 177

  22. Longitudinal biomarkers in amyotrophic lateral sclerosis

    Authors: , , , , , , , , , , , , , , - Annals of Clinical and Translational Neurology 2020 cited by 114

  23. Exome-wide Rare Variant Analysis Identifies TUBA4A Mutations Associated with Familial ALS

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , José Luís Muñoz-Blanco, Michael A. Simpson, Wouter van Rheenen, Frank P. Diekstra, Giuseppe Lauria, Stefano Duga, Stefania Corti, Cristina Cereda, Lucia Corrado, Gianni Sorarú, Karen Morrison, Kelly L. Williams, Garth A. Nicholson, Ian P. Blair, Patrick A. Dion, Claire S. Leblond, Guy A. Rouleau, Orla Hardiman, Jan H. Veldink, Leonard H. van den Berg, Ammar Al‐Chalabi, Hardev Pall, Pamela J. Shaw, Martin R. Turner, Kevin Talbot, Franco Taroni, Alberto García‐Redondo, Zheyang Wu, Jonathan D. Glass, Cinzia Gellera, Antonia Ratti, Robert H. Brown, Vincenzo Silani, Christopher E. Shaw, John E. Landers, Sandra D’Alfonso, Letizia Mazzini, Giacomo P. Comi, Roberto Del Bo, Mauro Ceroni, Stella Gagliardi, Giorgia Querin, Cinzia Bertolin - Neuron 2014 cited by 370

  24. Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72 -associated amyotrophic lateral sclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Carla Palmucci, A. Robertson, Michael G. Heckman, Nancy N. Diehl, Edythe Wiggs, Michael Tierney, Laura Braun, Jennifer Farren, David Lacomis, Shafeeq Ladha, Christina Fournier, Leo McCluskey, Lauren Elman, Jon B. Toledo, Jennifer D. McBride, Cinzia Tiloca, Claudia Morelli, Barbara Poletti, Federica Solca, A. Prelle, Joanne Wuu, Jennifer Jockel‐Balsarotti, Frank Rigo, Christine Ambrose, Abhishek Datta, Weixing Yang, Denitza Raitcheva, Giovanna Antognetti, Alexander McCampbell, John C. van Swieten, Bruce L. Miller, Adam L. Boxer, Robert H. Brown, Robert Bowser, Timothy M. Miller, John Q. Trojanowski, Murray Grossman, James D. Berry, William T. Hu, Antonia Ratti, Bryan J. Traynor, Matthew D. Disney, Michael Benatar, Vincenzo Silani, Jonathan D. Glass, Mary Kay Floeter, Jeffrey D. Rothstein, Khrista Boylan, Leonard Petrucelli - Science Translational Medicine 2017 cited by 268